Prevention of early-onset group B streptococcal disease in neonates [1] (multiple letters)

New England Journal of Medicine

Volumn 347, Issue 22, 2002, Pages 1798-1799

  Fay, David L ^a   Wenninger, Chris J ^a   Khandelwal, Meena ^b   Harmanli, Ozgur H ^b   Schrag, Stephanie J ^c   Schuchat, Anne ^c   Mohle Boetani, Janet ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STREPTOCOCCUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIURIA; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ETHNOLOGY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; LETTER; NEWBORN INFECTION; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VACCINATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; FEMALE; METHODOLOGY; NOTE; PATIENT SELECTION; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; ECONOMICS; MASS SCREENING;

COHORT STUDIES; FEMALE; HUMAN; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; HUMANS; ANTIBIOTIC PROPHYLAXIS; COST-BENEFIT ANALYSIS; MASS SCREENING;

EID: 0037191721     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200211283472213     Document Type: Letter

References (0)